NASDAQ: YBYuanbao Inc Stock
$15.55-0.27 (-1.71%)
Updated Jun 16, 2026
YB Price
$15.55
Fair Value Price
N/A
Market Cap
$702.53M
52 Week Low
$12.08
52 Week High
$31.00
P/E
2.14x
P/B
1.27x
P/S
1.16x
PEG
N/A
Dividend Yield
N/A
Revenue
$694.99M
Earnings
$98.22M
Gross Margin
96.4%
Operating Margin
17.83%
Profit Margin
44.1%
Debt to Equity
0.46
Operating Cash Flow
N/A
Beta
0.78
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
YB Overview
Yuanbao Inc., operating through its subsidiaries, manages an online platform for insurance distribution and various related services throughout the People's Republic of China. The company offers a diverse portfolio of insurance policies, including medical, critical illness, and life coverage. Beyond its core insurance offerings, it also provides specialized system services, which encompass precise marketing strategies and advanced analytics capabilities. Yuanbao Inc. was founded in 2019 and maintains its corporate headquarters in Beijing, China.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine YB's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: App
Industry Rating
B
YB
Ranked#67 of 175
Ranked#67 of 175
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $1.81 | A | |
| $2.81 | A | |
| $38.05 | A |
Be the first to know about important YB news, forecast changes, insider trades & much more!
YB News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how YB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
YB is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
YB is good value based on its earnings relative to its share price (2.14x), compared to the US market average (13.25x)
P/E vs Market Valuation
YB is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more YB due diligence checks available for Premium users.
Valuation
YB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
2.14x
Industry
54.15x
Market
13.25x
YB is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
YB is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
YB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.27x
Industry
4.99x
YB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
YB's financial health
Profit margin
Revenue
$190.7M
Net Income
$56.2M
Profit Margin
29.5%
YB's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$791.3M
Liabilities
$247.9M
Debt to equity
0.46
YB's short-term assets ($771.71M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
YB's short-term assets ($771.71M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
YB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
YB vs App Stocks
Yuanbao Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.